New Jersey § 24:21-7

§ 24:21-7.

a. Tests. The director shall place a substance in Schedule III if he finds that the substance: (1) has

a potential for abuse less than the substances listed in Schedules I and II; 1 (2) has currently accepted medical use in treatment in the United States; and (3)

abuse may lead to moderate or low physical dependence or high psychological dependence. b. The controlled dangerous substances listed in this section are included in Schedule

III, subject to any revision and republishing by the director pursuant to subsection d. of section 3 of P.L.1970, c. 226 ( C.24:21-3 ) , and except to the extent provided in any other schedule. c. Any material, compound, mixture, or preparation which contains any quantity of

the following substances associated with a stimulant effect on the central nervous

system: (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers. (2) Phenmetrazine and its salts. (3) Any substance which contains any quantity of methamphetamine, including its salts,

isomers, and salts of isomers. (4) Methylphenidate. d. Any material, compound, mixture, or preparation which contains any quantity of

the following substances having a potential for abuse associated with a depressant

effect on the central nervous system: (1) Any substance which contains any quantity of a derivative of barbituric acid,

or any salt of a derivative of barbituric acid, except those substances which are

specifically listed in other schedules (2) Chlorhexadol (3) Glutethimide (4) Lysergic acid (5) Lysergic acid amide (6) Methyprylon (7) Phencyclidine (8) Sulfondiethylmethane (9) Sulfonethylmethane (10) Sulfonmethane (11) Ketamine hydrochloride. e. Nalorphine. f. Any material, compound, mixture, or preparation containing limited quantities of

any of the following narcotic drugs, or any salts thereof: (1) Not more than 1.80 grams of codeine or any of its salts per 100 milliliters or

not more than 90 milligrams per dosage unit, with an equal or greater quantity of

an isoquinoline alkaloid of opium. (2) Not more than 1.80 grams of codeine or any of its salts per 100 milliliters or

not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic

ingredients in recognized therapeutic amounts. (3) Not more than 300 milligrams of dihydrocodeinone or any of its salts per 100 milliliters

or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity

of an isoquinoline alkaloid of opium. (4) Not more than 300 milligrams of dihydrocodeinone or any of its salts per 100 milliliters

or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic

ingredients in recognized therapeutic amounts. (5) Not more than 1.80 grams of dihydrocodeine or any of its salts per 100 milliliters

or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic

ingredients in recognized therapeutic amounts. (6) Not more than 300 milligrams of ethylmorphine or any of its salts per 100 milliliters

or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic

ingredients in recognized therapeutic amounts. (7) Not more than 500 milligrams of opium or any of its salts per 100 milliliters

or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more

active, nonnarcotic ingredients in recognized therapeutic amounts. (8) Not more than 50 milligrams of morphine or any of its salts per 100 milliliters

or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic

amounts. g. The director may by regulation except any compound, mixture, or preparation containing any stimulant

or depressant substance listed in subsections c . and d . of this schedule from the application of all or any part of this act if the compound,

mixture, or preparation contains one or more active medicinal ingredients not having

a stimulant or depressant effect on the central nervous system; provided, that such

admixtures shall be included therein in such combinations, quantity, proportion, or

concentration as to vitiate the potential for abuse of the substances which do have

a stimulant or depressant effect on the central nervous system. 1

N.J.S.A. §§ 24:21-5, 24:21-6.